REQUEST A DEMO
Total
USD $0.00
Search more companies

Cheil Bio Co.,Ltd. (South Korea)

Main Activities: Animal Food Manufacturing | Pharmaceutical and Medicine Manufacturing
Full name: Cheil Bio Co.,Ltd. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Cheil Bio Company is an animal medicine manufacturer. The company focuses on developing pharmaceutical products for the promotion of animal health. Cheil Bio Company is engaged in research and development in the field of animal pharmaceuticals and has received awards for its excellence.

Headquarters
456-2 Moknae-Dong, Ahnsan-Si
Ansan; Gyeonggi; Postal Code: 425-100

Contact Details: Purchase the Cheil Bio Co.,Ltd. report to view the information.

Website: http://www.cheilbio.com

Basic Information
Total Employees:
Purchase the Cheil Bio Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Cheil Bio Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Cheil Bio Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Cheil Bio Co.,Ltd. report to view the information.
Incorporation Date:
February 21, 1989
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
32.292%
Purchase this report to view the information.
0.2%
Purchase this report to view the information.
0.2%
Purchase this report to view the information.
0.2%
Purchase this report to view the information.
0.056%
Subsidiaries
(주)제일바이오
Company Performance
Financial values in the chart are available after Cheil Bio Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-21.1%
Total operating revenue
-25.13%
Operating profit (EBIT)
5.56%
EBITDA
-390.1%
Net Profit (Loss) for the Period
15.34%
Total assets
-2.41%
Total equity
-5.93%
Operating Profit Margin (ROS)
-3.02%
Net Profit Margin
-0.81%
Return on Equity (ROE)
0.52%
Debt to Equity Ratio
0.39%
Quick Ratio
-11.13%
Cash Ratio
-10.78%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?